Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
申请人:——
公开号:US20020156098A1
公开(公告)日:2002-10-24
Methods for treating, preventing or inhibiting leishmaniasis in a subject comprising administering to the subject a therapeutically effective amount of at least one compound having the structural formula
1
wherein Y is a heteroatom; R
1
and R
2
are independently H or an alkyl, cycloalkyl, heterocycloalkyl, aryl, amino or heteroaryl group; and X
1
, X
2
, and X
3
are independently H or an alkyl, alkoxy, halo, amino, alkylamino, dialkylamino, acylamino, alkylthio, sulfonyl, cyano, carboxy, alkoxycarbonyl, or carbamoyl group are disclosed.
Novel amidine compounds for treating microbial infections
申请人:Tidwell R. Richards
公开号:US20070088067A1
公开(公告)日:2007-04-19
Novel amidine and diamidine compounds are useful in the treatment of microbial infections, including mycobacterial, fungal and protozoal infections. Pharmaceutical formulations comprising these compounds can be used in methods of treating microbial infections.
NOVEL AMIDINE COMPOUNDS FOR TREATING MICROBIAL INFECTIONS
申请人:UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
公开号:EP1663959A1
公开(公告)日:2006-06-07
US6706754B2
申请人:——
公开号:US6706754B2
公开(公告)日:2004-03-16
[EN] REVERSED AMIDINES AND METHODS OF USING FOR TREATING, PREVENTING, OR INHIBITING LEISHMANIASIS<br/>[FR] AMIDINES INVERSEES ET METHODES D'UTILISATION POUR TRAITER, PREVENIR, ET INHIBER LA LEISHMANIOSE
申请人:US ARMY MED RES MAT COMMAND
公开号:WO2002036588A2
公开(公告)日:2002-05-10
Methods for treating, preventing or inhibiting leishmaniasis in a subject comprising administering to the subject a therapeutically effective amount of at least one compound having the structural formula (I) wherein Y is a heteroatom; R?1 and R2¿ are independently H or an alkyl, cycloalkyl, heterocycloalkyl, aryl, amino or heteroaryl group; and X1, X2, and X¿3? are independently H or an alkyl, alkoxy, halo, amino, alkylamino, dialkylamino acylamino, alkylthio, sulfonyl, cyano, carboxy alkoxycarbonyl, or carbamoyl group are disclosed.